Needles Market Growth and Status Explored in a New Research Report 2035

The concept of innovative needles holds immense potential to transform the treatment approaches for chronic diseases. The integration of various advanced technologies have facilitated the smooth transition of needles from research to clinical application.

The global needles market size is projected to grow from $8.1 billion in 2025 to $14.7 billion by 2035, representing a CAGR of 6.1% during the forecast period.

Needles have emerged as a critical tool in healthcare as they are being used for a variety of purposes, including drug delivery, vaccination and body fluid extraction.  It is worth mentioning that their design and functionality have evolved significantly since their inception in the 19th century, impacting both clinical practices and patient experiences. During our research, we identified over 475 needle providers engaged in the global needles market.

The needles market is highly fragmented, featuring the presence of both established companies as well as emerging start-ups. Most (200) of the needle manufacturers and developers were established between 1991-2010. Notably, seven players have entered the domain post-2020; these include (in reverse chronological order) White Plus Innovations (2023), Fostech Solutions (2022), Calminject (2021), Corza Medical (2021), Neucell (2021), Nubeno Healthcare (2021) and Suyash Healthcare (2021).

Majority (250) of the companies provide needles that administer drugs via intravenous route. This is indicative of the fact that this intravenous mode of delivery enables faster absorption of medications into the bloodstream, leading to a rapid onset of therapeutic action as compared to other modes of delivery.  This is followed by the companies providing needles that are capable of administering drugs via hypodermic (221) and subcutaneous (162) route. It is worth mentioning that subcutaneous route is less painful, owing to the integration of shorter and thinner needles.  Notable examples of companies providing needles to administer medications via subcutaneous route include (based in France, in alphabetical order) Perouse, Pikdare, SUTUREX & RENODEX and Vygon.

The majority of the blood collection needles (121) are safety needles. This can be attributed to the retractable nature of safety needles that prevents needlestick injuries. Further, it is observed that most of the suture needles are conventional needles. This is an indicative of the fact that surgical procedures involve the usage of conventional needles because of their ability to penetrate through epidermal tissues like skin, which is essential to achieve precise suturing results. ,   Examples of the players using conventional suture needles include (based in Turkey, in alphabetical order) Aleda Makina, Setpa and SKY Biotechnology.

Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Needles Market. 

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

Read More :- https://www.rootsanalysis.com/reports/needles-market.html